Loading…

A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism

Astrocytes are major players in brain glucose metabolism, supporting neuronal needs on demand through mechanisms that are not yet entirely clear. Understanding glucose metabolism in astrocytes is therefore of great consequence to unveil novel targets and develop new drugs to restore brain energy bal...

Full description

Saved in:
Bibliographic Details
Published in:Neuropharmacology 2018-07, Vol.136 (Pt B), p.216-222
Main Authors: Fernandez, Ana M., Hernandez, Edwin, Guerrero-Gomez, David, Miranda-Vizuete, Antonio, Torres Aleman, Ignacio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3
cites cdi_FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3
container_end_page 222
container_issue Pt B
container_start_page 216
container_title Neuropharmacology
container_volume 136
creator Fernandez, Ana M.
Hernandez, Edwin
Guerrero-Gomez, David
Miranda-Vizuete, Antonio
Torres Aleman, Ignacio
description Astrocytes are major players in brain glucose metabolism, supporting neuronal needs on demand through mechanisms that are not yet entirely clear. Understanding glucose metabolism in astrocytes is therefore of great consequence to unveil novel targets and develop new drugs to restore brain energy balance in pathology. Contrary to what has been held for many years, we now present evidence that insulin, in association with the related insulin-like growth factor I (IGF-I) modulates brain glucose metabolism through a concerted action on astrocytes. Cooperativity of insulin and IGF-I relies on the IGF-I receptor (IGF-IR), that acts as a scaffold of Glucose Transporter 1 (GluT1) regulating its activity by retaining it in the cytoplasm or, in response to a concerted action of insulin and IGF-I, translocating it to the cell membrane. Regulated translocation of GluT1 to the cell membrane by IGF-IR involves an intricate repertoire of protein-protein interactions amenable to drug modulation, particularly by interfering with IGF-IR/GluT1 interactions. We propose that this mechanism accounts for a substantial proportion of basal and regulated glucose uptake by astrocytes as GluT1 is the major glucose transporter in these brain cells. This article is part of the Special Issue entitled ‘Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.’ •Insulin and IGF-I act in concert to stimulate glucose uptake.•IGF-IR acts as a scaffold for GluT1 in astrocytes.•Ligand-independent actions of IGF-IR and IR on astrocyte glucose handling are.•antagonistic.
doi_str_mv 10.1016/j.neuropharm.2017.08.034
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1935810316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390817304148</els_id><sourcerecordid>1935810316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3</originalsourceid><addsrcrecordid>eNqFkMtu1TAURS0EopeWX0AeMknqRx4Os1IBRarUDujY8uM49a0TB9tpdQf8O6lugSGjM1l7b52FEKakpoR25_t6hjXF5V6lqWaE9jURNeHNK7SjoudVT7rmNdoRwkTFByJO0Luc94SQRlDxFp0wIdpBiGaHfl3gGcpTTA84OuznvAY_4wWW4i1knGBcgyqAx7CamAGvS1EPgPUBq1xSNIcC-RO-jQXm4lXYyp6wTes4Kh0AF5VGKBm7mLBOamu-PyxxgqJ0DD5PZ-iNUyHD-5d7iu6-fvlxeVVd33z7fnlxXZmmIaXqW6qBcqtbYmg_sIYzJgbGrO6sM70zVtmud8pxS1tju8FQZ6FhbWvaQWvNT9HHY--S4s8VcpGTzwZCUDPENUs68FZQwmm3oeKImhRzTuDkkvyk0kFSIp_ly738J18-y5dEyE3-Fv3wsrLqCezf4B_bG_D5CMD266OHJLPxMBuwPoEp0kb__5XfbFifcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1935810316</pqid></control><display><type>article</type><title>A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism</title><source>ScienceDirect Journals</source><creator>Fernandez, Ana M. ; Hernandez, Edwin ; Guerrero-Gomez, David ; Miranda-Vizuete, Antonio ; Torres Aleman, Ignacio</creator><creatorcontrib>Fernandez, Ana M. ; Hernandez, Edwin ; Guerrero-Gomez, David ; Miranda-Vizuete, Antonio ; Torres Aleman, Ignacio</creatorcontrib><description>Astrocytes are major players in brain glucose metabolism, supporting neuronal needs on demand through mechanisms that are not yet entirely clear. Understanding glucose metabolism in astrocytes is therefore of great consequence to unveil novel targets and develop new drugs to restore brain energy balance in pathology. Contrary to what has been held for many years, we now present evidence that insulin, in association with the related insulin-like growth factor I (IGF-I) modulates brain glucose metabolism through a concerted action on astrocytes. Cooperativity of insulin and IGF-I relies on the IGF-I receptor (IGF-IR), that acts as a scaffold of Glucose Transporter 1 (GluT1) regulating its activity by retaining it in the cytoplasm or, in response to a concerted action of insulin and IGF-I, translocating it to the cell membrane. Regulated translocation of GluT1 to the cell membrane by IGF-IR involves an intricate repertoire of protein-protein interactions amenable to drug modulation, particularly by interfering with IGF-IR/GluT1 interactions. We propose that this mechanism accounts for a substantial proportion of basal and regulated glucose uptake by astrocytes as GluT1 is the major glucose transporter in these brain cells. This article is part of the Special Issue entitled ‘Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.’ •Insulin and IGF-I act in concert to stimulate glucose uptake.•IGF-IR acts as a scaffold for GluT1 in astrocytes.•Ligand-independent actions of IGF-IR and IR on astrocyte glucose handling are.•antagonistic.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2017.08.034</identifier><identifier>PMID: 28859884</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Astrocytes ; Brain glucose metabolism ; Daf-2 ; Glucose transporter 1 ; Glucose uptake ; IGF-I ; Insulin ; Insulin and IGF-I receptors</subject><ispartof>Neuropharmacology, 2018-07, Vol.136 (Pt B), p.216-222</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3</citedby><cites>FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28859884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fernandez, Ana M.</creatorcontrib><creatorcontrib>Hernandez, Edwin</creatorcontrib><creatorcontrib>Guerrero-Gomez, David</creatorcontrib><creatorcontrib>Miranda-Vizuete, Antonio</creatorcontrib><creatorcontrib>Torres Aleman, Ignacio</creatorcontrib><title>A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Astrocytes are major players in brain glucose metabolism, supporting neuronal needs on demand through mechanisms that are not yet entirely clear. Understanding glucose metabolism in astrocytes is therefore of great consequence to unveil novel targets and develop new drugs to restore brain energy balance in pathology. Contrary to what has been held for many years, we now present evidence that insulin, in association with the related insulin-like growth factor I (IGF-I) modulates brain glucose metabolism through a concerted action on astrocytes. Cooperativity of insulin and IGF-I relies on the IGF-I receptor (IGF-IR), that acts as a scaffold of Glucose Transporter 1 (GluT1) regulating its activity by retaining it in the cytoplasm or, in response to a concerted action of insulin and IGF-I, translocating it to the cell membrane. Regulated translocation of GluT1 to the cell membrane by IGF-IR involves an intricate repertoire of protein-protein interactions amenable to drug modulation, particularly by interfering with IGF-IR/GluT1 interactions. We propose that this mechanism accounts for a substantial proportion of basal and regulated glucose uptake by astrocytes as GluT1 is the major glucose transporter in these brain cells. This article is part of the Special Issue entitled ‘Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.’ •Insulin and IGF-I act in concert to stimulate glucose uptake.•IGF-IR acts as a scaffold for GluT1 in astrocytes.•Ligand-independent actions of IGF-IR and IR on astrocyte glucose handling are.•antagonistic.</description><subject>Astrocytes</subject><subject>Brain glucose metabolism</subject><subject>Daf-2</subject><subject>Glucose transporter 1</subject><subject>Glucose uptake</subject><subject>IGF-I</subject><subject>Insulin</subject><subject>Insulin and IGF-I receptors</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkMtu1TAURS0EopeWX0AeMknqRx4Os1IBRarUDujY8uM49a0TB9tpdQf8O6lugSGjM1l7b52FEKakpoR25_t6hjXF5V6lqWaE9jURNeHNK7SjoudVT7rmNdoRwkTFByJO0Luc94SQRlDxFp0wIdpBiGaHfl3gGcpTTA84OuznvAY_4wWW4i1knGBcgyqAx7CamAGvS1EPgPUBq1xSNIcC-RO-jQXm4lXYyp6wTes4Kh0AF5VGKBm7mLBOamu-PyxxgqJ0DD5PZ-iNUyHD-5d7iu6-fvlxeVVd33z7fnlxXZmmIaXqW6qBcqtbYmg_sIYzJgbGrO6sM70zVtmud8pxS1tju8FQZ6FhbWvaQWvNT9HHY--S4s8VcpGTzwZCUDPENUs68FZQwmm3oeKImhRzTuDkkvyk0kFSIp_ly738J18-y5dEyE3-Fv3wsrLqCezf4B_bG_D5CMD266OHJLPxMBuwPoEp0kb__5XfbFifcQ</recordid><startdate>20180701</startdate><enddate>20180701</enddate><creator>Fernandez, Ana M.</creator><creator>Hernandez, Edwin</creator><creator>Guerrero-Gomez, David</creator><creator>Miranda-Vizuete, Antonio</creator><creator>Torres Aleman, Ignacio</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180701</creationdate><title>A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism</title><author>Fernandez, Ana M. ; Hernandez, Edwin ; Guerrero-Gomez, David ; Miranda-Vizuete, Antonio ; Torres Aleman, Ignacio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Astrocytes</topic><topic>Brain glucose metabolism</topic><topic>Daf-2</topic><topic>Glucose transporter 1</topic><topic>Glucose uptake</topic><topic>IGF-I</topic><topic>Insulin</topic><topic>Insulin and IGF-I receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fernandez, Ana M.</creatorcontrib><creatorcontrib>Hernandez, Edwin</creatorcontrib><creatorcontrib>Guerrero-Gomez, David</creatorcontrib><creatorcontrib>Miranda-Vizuete, Antonio</creatorcontrib><creatorcontrib>Torres Aleman, Ignacio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fernandez, Ana M.</au><au>Hernandez, Edwin</au><au>Guerrero-Gomez, David</au><au>Miranda-Vizuete, Antonio</au><au>Torres Aleman, Ignacio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2018-07-01</date><risdate>2018</risdate><volume>136</volume><issue>Pt B</issue><spage>216</spage><epage>222</epage><pages>216-222</pages><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>Astrocytes are major players in brain glucose metabolism, supporting neuronal needs on demand through mechanisms that are not yet entirely clear. Understanding glucose metabolism in astrocytes is therefore of great consequence to unveil novel targets and develop new drugs to restore brain energy balance in pathology. Contrary to what has been held for many years, we now present evidence that insulin, in association with the related insulin-like growth factor I (IGF-I) modulates brain glucose metabolism through a concerted action on astrocytes. Cooperativity of insulin and IGF-I relies on the IGF-I receptor (IGF-IR), that acts as a scaffold of Glucose Transporter 1 (GluT1) regulating its activity by retaining it in the cytoplasm or, in response to a concerted action of insulin and IGF-I, translocating it to the cell membrane. Regulated translocation of GluT1 to the cell membrane by IGF-IR involves an intricate repertoire of protein-protein interactions amenable to drug modulation, particularly by interfering with IGF-IR/GluT1 interactions. We propose that this mechanism accounts for a substantial proportion of basal and regulated glucose uptake by astrocytes as GluT1 is the major glucose transporter in these brain cells. This article is part of the Special Issue entitled ‘Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.’ •Insulin and IGF-I act in concert to stimulate glucose uptake.•IGF-IR acts as a scaffold for GluT1 in astrocytes.•Ligand-independent actions of IGF-IR and IR on astrocyte glucose handling are.•antagonistic.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28859884</pmid><doi>10.1016/j.neuropharm.2017.08.034</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2018-07, Vol.136 (Pt B), p.216-222
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_1935810316
source ScienceDirect Journals
subjects Astrocytes
Brain glucose metabolism
Daf-2
Glucose transporter 1
Glucose uptake
IGF-I
Insulin
Insulin and IGF-I receptors
title A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A56%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20network%20of%20insulin%20peptides%20regulate%20glucose%20uptake%20by%20astrocytes:%20Potential%20new%20druggable%20targets%20for%20brain%20hypometabolism&rft.jtitle=Neuropharmacology&rft.au=Fernandez,%20Ana%20M.&rft.date=2018-07-01&rft.volume=136&rft.issue=Pt%20B&rft.spage=216&rft.epage=222&rft.pages=216-222&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2017.08.034&rft_dat=%3Cproquest_cross%3E1935810316%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-751be13db50c179243228922db6dfc7fcdad67faf3d15cd69c1fde4255c59bbb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1935810316&rft_id=info:pmid/28859884&rfr_iscdi=true